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Abstract Here we report the isolation of a cDNA encoding the
complete human rab18 protein from histamine-stimulated
endothelial cells using differential display. The amino acid
sequence showed 98% homology with the previously isolated
mouse rab18 protein, which is implicated in apical/basolateral
endocytosis. Northern blot analysis revealed two transcripts (2.5
kb and 1 kb) ubiquitously expressed in all examined organs, as
well as in human umbilical vein endothelial and aortic cells. In
blood cells rab18 transcripts were hardly detectable. The
histamine-induced time-dependent increase of rab18 mRNA
expression in human umbilical vein endothelial cells and
peripheral blood mononuclear cells indicates for the first time a
link between receptor-mediated signal transduction and the
regulation of rab gene expression. This finding might also imply
a role for rab proteins in inflammation.
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1. Introduction
Rab proteins, a family of ras-related small GTPases, have
been known to be key regulators of membrane tra⁄cking for
more than a decade (for a recent review see [1]). More than 30
di¡erent rab proteins have been identi¢ed and localised on
di¡erent organelles and transport vesicles in mammals [2].
We report here the isolation of the complete human rab18
cDNA from human umbilical vein endothelial cells (HU-
VECs) stimulated by the in£ammatory mediator histamine.
Isolation and characterisation of the rab18 gene from mouse
pituitary AtT-20 cells and adult mouse kidney has shed some
light on the possible function of the gene product. The mouse
rab18 mRNA seems to be equally expressed in polarised and
non-polarised cells [3,4]. However, intracellular localisation in
organ cryosections demonstrated the rab18 protein to be ex-
pressed in a tissue- and cell type-dependent manner in mouse
kidney and intestines [4]. The rab18 protein was detected in
apical endocytic structures in polarised epithelial cells of kid-
ney proximal tubules. However, the rab18 protein does not
seem to be restricted to the apical transport machinery of all
polarised cells, since the protein was also localised on both the
apical and basolateral domains in epithelial cells of the intes-
tines. A role of rab18 in the transport between the plasma
membrane and early endosomes was discussed in this context.
The genetic mapping of rab18 on the mouse chromosome
18 and alignment with the consensus map of mouse chromo-
some 18 showed rab18 to be coincident with two neighbour-
ing mutations, Tw (twirler) and ax (ataxia) which result in
neurological abnormalities. These ¢ndings and the detection
of rab18 transcript in the brain [4] led to the suggestion that
rab18 might be a potential candidate gene for these mutations
[5]. Furthermore, rab proteins have been shown in previous
studies to participate in the function of brain synaptic vesicles
[6,7].
The recognition of rab proteins as key elements in vesicle
transport has led to further investigations into the physiolog-
ical regulation of rab-mediated membrane tra⁄cking. Thus,
agonist-regulated post-transcriptional processing, such as
phosphorylation or geranylgeranylation, has been described
for rab3, rab3B, rab4, rab6, and rab8 proteins. The activation
of platelets by thrombin, a potent inducer of secretion, re-
sulted in the phosphorylation of rab3B, rab6, and rab8 pro-
teins [8]. The active form of rab8 has also been shown to
interact with a stress-activated protein kinase in transfected
293 T cells, indicating that rab-regulated protein phosphory-
lation may serve to modulate secretion in response to stress
stimuli [9]. In both 3T3 L1 ¢broblasts and adipocytes the
amount of geranylgeranylated rab3 and rab4 proteins was
increased by insulin, indicating insulin as an activator of the
membrane tra⁄cking machinery in the above mentioned cell
systems [10].
Although agonist- or stress-induced post-translational pro-
cessing of rab proteins has been described to some extent,
reports on the regulation of gene expression of rab proteins
are scarce. Di¡erential expression of rab genes has been
shown in di¡erentiating phagocytes [11] and during develop-
mental regulation in Drosophila, Dictyostelium and maize [12^
14].
It was our aim to identify and characterise genes which are
di¡erentially expressed in human endothelial cells during early
in£ammation. The chosen approach, that is stimulation of
HUVECs with histamine and subsequent analysis of gene ex-
pression by di¡erential display, was based on the very well
documented in£ammatory characteristics of histamine. Hista-
mine has been proven to be one of the mediators released
early during in£ammatory events, such as anaphylactic reac-
tions, shock and sepsis [15^17]. Focusing on the histamine-
induced in£ammatory e¡ects, we were able to show that his-
tamine rapidly stimulates endothelial cell responses, such as
adhesion of neutrophils to endothelial cells [18] and mediator
release (unpublished observations).
This report demonstrates that expression of the human
rab18 gene isolated from activated HUVECs is also rapidly
induced by histamine. To our knowledge regulation of rab
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gene expression as a response to physiological stimuli has only
been shown in plants. This is the ¢rst report demonstrating
e¡ector-regulated mRNA expression of a human rab gene.
2. Materials and methods
2.1. Cell culture
Cryopreserved HUVECs (Cell Systems) were cultured in EBM me-
dium (Clonetics) supplemented with EGM SingleQuots (0.01 Wg/ml
hEGF, 1 Wg/ml hydrocortisone, 50 Wg/ml gentamicin sulphate, 50
Wg/ml amphotericin B, 12 Wg/ml bovine brain extract) and 10% foetal
calf serum (Life Technologies) at 37‡C, 5% CO2, 95% air. Endothelial
cells were cultured at a concentration of 7U105 cells/5 ml medium in
25 cm2 Falcon £asks (Becton Dickinson). Medium was exchanged
every 48 h. Endothelial cell cultures were used from the second
through the seventh passage as recommended by Clonetics.
Culture medium was removed from tightly con£uent cells and sub-
stituted by medium containing histamine (1 mM). The histamine con-
centration was determined previously [18]. The cells were incubated
for various times in an atmosphere of 5% CO2, 95% air at 37‡C.
2.2. Isolation of human blood cells
Human blood cells were isolated from venous blood of healthy
donors by a two-step Percoll density gradient centrifugation. 7 ml
of heparinised (100 IU/ml) venous blood was carefully layered over
a discontinuous gradient of isotonic Percoll (solution 1 = 1.1026 g/ml,
solution 2 = 1.0776 g/ml) and centrifuged for 25 min at 350Ug at
room temperature. After centrifugation the granulocytes were col-
lected from the ¢rst interphase. Mononuclear cells were isolated
from the second interphase. Both cell types were washed twice with
PBS.
In a second step monocytes were isolated from mononuclear cells
by adhesion to cell culture £asks. Mononuclear cells were suspended
in RPMI medium and cultured for 2 h in Falcon £asks at 37‡C. After
washing twice with phosphate-bu¡ered saline (PBS) RNA was iso-
lated from collected non-adherent mononuclear cells and adherent
monocytes as described below.
2.3. Preparation and stimulation of peripheral blood mononuclear cells
(PBMNCs)
PBMNCs were isolated from heparinised venous blood of healthy
donors of both genders and various ages, using a Ficoll-Paque0 gra-
dient (Pharmacia, Uppsala, Sweden). 7.5 ml of RPMI containing 0.1%
bovine serum albumin and penicillin (100 U/ml)/streptomycin (100 Wg/
ml) was added to 7.5 ml of heparinised venous blood, then carefully
layered on 15 ml of Ficoll-Paque gradient. After centrifugation at
2000 rpm for 20 min, the interface was isolated and cells were washed
twice and then resuspended in RPMI medium. Cells were counted in a
Neubauer chamber. 2U106 cells were incubated in a total volume of
10 ml of RPMI medium in the presence or absence of histamine (1035
M) at 37‡C, 5% CO2, 95% humidi¢ed air. At this concentration via-
bility always exceeded 98% as judged by trypan blue exclusion. In-
cubation of PBMNCs with higher histamine concentrations resulted
in toxic e¡ects. Stimulation times were 5, 15, 120 or 360 min. Stim-
ulation was terminated by centrifugation at 2000 rpm for 10 min, then
cells were washed once and diluted in 1 ml RPMI medium.
2.4. RNA isolation
Culture medium was decanted, cells were washed in PBS (NaCl 120
mM, KH2PO4 2.7 mM, Na2HPO4 10 mM) and lysed by incubation
with Trizol reagent (Life Technologies). After phenol/chloroform ex-
traction and ethanol precipitation, samples were redissolved in dieth-
ylpyrocarbonate-treated sterile water.
2.5. Di¡erential display
Di¡erential display was performed according to the protocol pub-
lished by Liang and Pardee [19]. 2 Wg total RNA was treated with
RNase-free DNase (Boehringer Mannheim) in the presence of 40 U
recombinant RNase inhibitor (Life Technologies) to remove contam-
inating genomic DNA. After phenol/chloroform extraction and etha-
nol precipitation, samples were redissolved in diethylpyrocarbonate-
treated sterile water at a concentration of 250 ng/Wl. 500 ng RNA
from each sample was reverse transcribed with Thermoscript (Life
Technologies) at 60‡C in the presence of 1 WM 5P-AAAGAC-
CACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTTTV-3P and
0.5 mM dNTPs for 60 min. After reverse transcription, 2 Wl of the
reaction mixture was taken for each of the following PCR reactions
using 5P-GACCACGCGTATCGATGTCGAC-3P as 3P-primer and 5P-
TGTGAGGAATGTGGGAAA-3P as 5P-primer. PCR reaction was
performed in the presence of 0.4 WM 3P-primer, 0.4 WM 5P-primer,
0.2 mM dNTPs, and 2.5 U Taq polymerase (Life Technologies). Cy-
cling parameters (25 cycles) were 94‡C for 20 s, 58‡C for 30 s, 68‡C
for 4 min and a ¢nal 10 min extension step at 68‡C after initial
incubation at 94‡C for 3 min. PCR products were separated on a
denaturing 5% polyacrylamide sequencing gel and visualised by silver
staining (Silver Stain Plus Kit, Bio-Rad) according to the manufac-
turer’s protocol. Fragments of interest were isolated by excising the
band from the wet gel. Gel slices were dissolved in 0.5 M ammonium
acetate, 10 mM magnesium acetate, 1 mM EDTA pH 8, and 0.1%
SDS. Following ethanol precipitation, the fragments were reampli¢ed
using the PCR conditions described above. PCR fragments were
cloned into the pCRP II Vector (Invitrogen) according to the manu-
facturer’s protocol.
2.6. RACE protocol
The RACE protocol was performed using the 5P/3PRACE kit
(Boehringer Mannheim) according to the manufacturer’s protocol.
For the ampli¢cation of the 3P-end 5P-GGGAAAGTGAGAACCA-
GAATAAAGGAG-3P was used as a forward primer for ¢rst round
PCR and 5P-AAGGAGGAGGAGCCTGTGGTGG-3P was used as a
nested forward primer for second round PCR. For the ampli¢cation
of the 5P-end 5P-GACTGCAAACTTGTGCATGCTTACC-3P was
used for reverse transcription. For ¢rst round PCR 5P-CTGCA-
AGGTCCCTAAATAGCAGTT-3P was used as a nested reverse
primer and 5P-GCAAGAGATGGAATTTCCCAGAG-3P was used
as a second nested reverse primer for second round PCR. PCR frag-
ments were cloned into the pCRP II Vector (Invitrogen) according to
the manufacturer’s protocol.
2.7. Sequence analysis
Sequence analysis was performed using the ABI Prism 277 Auto-
mated Sequencer (Applied Biosystems, USA). The sequence was de-
termined on both strands.
2.8. Preparation of probes for Northern blot hybridisation and Northern
blot analysis
The pCRQ II Vector (Invitrogen) was linearised with BamHI (Prom-
ega) at the multiple cloning site. Linearised vector DNA was isolated
from a 1% agarose gel according to the manufacturer’s protocol
(QIAquick Gel Extraction Kit, Qiagen). 1 Wg linearised vector DNA
was in vitro transcribed in a total volume of 20 Wl using the DIG
RNA labeling kit (Boehringer Mannheim) according to the manufac-
turer’s protocol with T7 RNA polymerase. Labelling e⁄ciency was
estimated in a spot test with a DIG-labelled control (Boehringer
Mannheim) as recommended by Boehringer.
For Northern blot analysis, 5 Wg total RNA was loaded per lane.
40 ng DIG-labelled RNA molecular weight marker I (Boehringer
Mannheim) was loaded in one lane as a marker. Probes were run
for 16 h at 23 V in formaldehyde-containing agarose gels (1%). Gels
were hydrolysed in 0.05 M NaOH for 20 min, washed three times in
DEPC-treated sterile water, and soaked in 20USSC for 2U15 min.
Gels were blotted on a positively charged Nylon membrane (Boeh-
ringer Mannheim) with 20USSC for 6 h at room temperature. Filters
were crosslinked using Stratagene’s crosslinker. After prehybridisa-
tion, ¢lters were hybridised at 68‡C for 16 h with 25 ng DIG-labelled
RNA probe per ml hybridisation solution (Dig easy hyb, Boehringer
Mannheim). Stringency washes were carried out twice with 0.4USSC/
0.1% SDS at 68‡C after washing twice with 2USSC/0.1% SDS at
room temperature. Filters were blocked for 30 min in 1Ublock so-
lution (Boehringer Mannheim), incubated with anti-digoxigenin-AP
Fab fragments (Boehringer Mannheim) 1:30 000 in 1Ublock solution
for 30 min, washed in 1Uwash solution (Boehringer Mannheim) and
incubated with CDP-star (Boehringer Mannheim) for 5 min. Finally
¢lters were exposed to Biomax light-1 ¢lms (Kodak). All experiments
were repeated at least twice.
2.9. Reverse transcription and polymerase chain reaction
In order to rule out genomic DNA contamination as an ampli¢ca-
tion source the RNA solution was incubated with DNase I (Boeh-
ringer, Mannheim) for 15 min at 37‡C. Reverse transcription and
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PCR was performed using the Titan1 One Tube RT-PCR system
(Boehringer Mannheim). Total RNA (250 ng) was added to all com-
ponents of the system in a total volume of 50 Wl : 0.2 mM each of
dATP, dCTP, dTTP and dGTP, 0.4 WM sense and antisense primer,
40 U RNase inhibitor (Life Technologies) in a bu¡er of 100 mM Tris-
acetate (pH 6.5), 10 Wl 5URT-PCR bu¡er (7.5 mM MgCl2), 2.5 Wl
DTT solution (100 mM) and 1 Wl enzyme mixture consisting of Taq
DNA polymerase, Pwo DNA polymerase and AMV reverse transcrip-
tase. The RT-PCR reaction was carried out using speci¢cally designed
primer sets for GAPDH: sense 5P-CCATGGAGAAGGCTGGGG-3P,
antisense 5P-CAAAGTTGTCATGGATGACC-3P [20], the GAPDH
primers were located in two di¡erent exons; human rab18: 5P- GCC-
GTCATCAACGACCTACATGG-3P as a forward primer and 5P-CC-
CATAGGAGTTGAAGCAGCGC-3P reverse primer. The tempera-
ture cycles for amplifying GAPDH and rab18 cDNA consisted of:
30 min reverse transcriptase reaction at 55‡C, 3 min of denaturing at
94‡C (1 cycle), 30 s of denaturing at 94‡C, 30 s primer annealing at
58‡C, 90 s of primer extension at 72‡C (35 cycles), 7 min primer
extension at 72‡C (1 cycle) (Thermocycler PC-9606/Corbett). 15 Wl
aliquots of the PCR product were fractionated by horizontal gel elec-
trophoresis on a 1.5% agarose ethidium bromide-stained gel.
2.10. Tissue distribution
Tissue distribution was evaluated using PCR ampli¢cation with the
human rab18 gene-speci¢c primers described above from normalised
cDNA (Clontech) according to the manufacturer’s protocol. In brief
2 Wl from each tissue-speci¢c cDNA was used as template. PCR re-
action was performed in the presence of 0.3 WM of each primer,
0.2 mM dNTPs, and 2.5 U Taq polymerase (Life technologies). Cy-
cling parameters (35 cycles) were 94‡C for 20 s, 64‡C for 30 s, 72‡C
for 60 s and a ¢nal 5 min extension step at 72‡C after initial incuba-
tion at 94‡C for 3 min. PCR products were separated on a 1.5%
agarose gel and photographed. Experiments were repeated three
times.
2.11. High performance liquid chromatography
PCR reaction products were quanti¢ed by size fractionation
through anionic exchange high performance liquid chromatography
(HPLC) in a Waters LCM1 plus system, which includes two pumps
444, an automated gradient controller, an autosampler 712, a UV
detector 486 and a data module 746 for data analysis. The column
was recalibrated for 10^12 min with a bu¡er ratio of 46/54 (A/B). The
total £ow rate was 1 ml/min. 10 Wl of the PCR reaction probe was
loaded on a prepacked DEAE-bonded non-porous resin particle col-
umn (diameter: 2.5 Wm). PCR products were separated by the follow-
ing gradient program: 0.01 min, 46/54 bu¡er A (25 mmol/l Tris^HCl,
pH 9.0, 1 mol/l NaCl)/bu¡er B (25 mmol/l Tris^HCl, pH 9.0);
0.50 min, 54/46 (A/B); 8 min, 64/36 (A/B). The elution pro¢le was
assessed at 260 nm. Peak areas corresponding to the PCR products,
detected at 260 nm by HPLC, were integrated and when essential
normalised to levels of GAPDH message (Millennium software,
Waters Corporation).
2.12. Statistical analysis
Normalised PCR products were integrated and displayed as per-
centage of control value. PCR product levels ampli¢ed from untreated
endothelial cell mRNA served as control values. Di¡erences in time
course between control values and the di¡erent time points were
tested using the paired Student’s t-test. Due to multiple comparisons,
only P-values 9 0.02 were considered signi¢cant. The results are dis-
played as means ( þ S.E.M.).
3. Results
3.1. Identi¢cation of the human rab18 protein sequence
Stimulation of HUVECs with histamine and subsequent
analysis of gene expression by di¡erential display led to the
identi¢cation of a di¡erentially expressed 612 bp cDNA frag-
ment. Cloning and sequence analysis revealed the cDNA frag-
ment to encode the 3P region of the human rab18 protein. The
complete rab18 cDNA clone was isolated using a RACE pro-
tocol.
The nucleotide and amino acid sequence of the human
rab18 are shown in Fig. 1a,b, respectively. Alignment of the
human rab18 protein sequence and the rab18 protein se-
quences previously isolated from other species, such as mouse,
snail and roundworm, revealed a high degree of homology
across the phylum (98%, 92% and 85%, respectively) (Fig.
1b).
Analysis of the amino acid sequences revealed a markedly
high interspecies homology at the structural features contrib-
uting towards GTP binding and functional speci¢city (Fig.
1b). The 100% interspecies homology observed in the con-
served nucleotide binding motifs PM1 (phosphate/Mg2 bind-
ing motif), PM3, as well as G1 (guanine base binding) and G3
extends into the PM1 adjacent L-strand 1 and the PM3 ad-
jacent switch II region, which includes loop 4/helix 2/loop 5
[21,22]. On the other hand, the highest degrees of variability
between the rab18 protein sequences of the analysed species
were observed in conserved regions de¢ning organelle target-
ing, such as helix 3/loop 7 and the C-terminal region [23,24].
These observations indicate a functional interspecies speci¢c-
ity of the rab18 protein which might not coincide with the
species-speci¢c localisation of rab18 on distinct membrane
compartments.
3.2. rab18 mRNA expression in di¡erent cell types and organs
Northern blot analysis using the 612 bp cDNA fragment as
a hybridisation probe resulted in two hybridisation signals
with a size of about 2.5 kb and 1 kb (Fig. 2). The size of
the larger transcript was consistent with the mouse rab18
mRNA size [4]. The expression of the smaller transcript co-
incided with the expression pattern of the 2.5 kb transcript.
Both signals were detected in venous and aortic endothelial
cells. The expression of both transcripts were hardly detect-
able in smooth muscle cells, PBMNCs, monocytes and neu-
trophils.
Tissue distribution of rab18 transcript was assessed by PCR
ampli¢cation. Using gene-speci¢c primers rab18 cDNAs were
ampli¢ed from tissue cDNA preparations (MTC1), which
were normalised using di¡erent housekeeping genes. Agarose
gel electrophoresis of the PCR products demonstrated cDNA
fragments corresponding to the expected rab18 cDNA frag-
ment size (592 bp) (Fig. 3). To con¢rm the origin of the
cDNA fragment, the PCR product was cloned and sequenced.
The homology between rab18 and the PCR product sequence
was 100%. Although rab18 mRNA was expressed ubiqui-
tously in all organs examined, the intensity of expression var-
ied between organs. Quanti¢cation of rab18 cDNA fragments
by HPLC revealed the rab18 transcript to be strongly ex-
pressed in heart, kidney, pancreas, lung and liver (Fig. 3, low-
er panel). Comparatively weak expression of rab18 mRNA
was observed in brain, placenta and skeletal muscle.
3.3. Histamine-induced upregulation of rab18 mRNA in
endothelial cells and PBMNCs
HUVECs and PBMNCs were stimulated with histamine
(1 mM and 10 WM, respectively) for increasing periods of
time in order to analyse the e¡ect of histamine on rab18
mRNA expression. The method of RT-PCR was employed
on total RNA extracted from stimulated and unstimulated
cells to detect changes in rab18 expression. GAPDH mRNA
was reverse transcribed and ampli¢ed from the same RNA
preparations as a control. In order to utilise the RT-PCR
products for semi-quantitation, the optimum number of am-
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pli¢cation cycles that were still in the linear range was deter-
mined for the two sets of gene-speci¢c primers.
The ampli¢cation products proved to be in the linear am-
pli¢cation phase at 32 cycles as determined by absorbance at
260 nm by HPLC (data not shown).
During 24 h of continuous histamine stimulation (1 mM)
the rab18 mRNA levels in endothelial cells increased by
92.2 þ 14% (P9 0.001) as compared to control levels (un-
stimulated endothelial cells) (Fig. 4). The histamine-stimulated
changes in rab18 level were concentration-dependent. After
24 h endothelial cell stimulation with 100 WM histamine the
rab18 message was increased by 80.7 þ 4.7% (P9 0.001). The
incubation of endothelial cells with 10 WM histamine did not
result in changes of rab18 mRNA levels (results not shown).
Initially a fast increase of rab18 transcript was observed
within 4 h of histamine stimulation (52.3 þ 9.1%; P9 0.001),
with a signi¢cant upregulation of rab18 transcript after 30
min (12 þ 5.2% (P9 0.001). These observations were in ac-
cordance with results initially obtained by Northern blot anal-
ysis showing an increase of the 2.4 kb and 1 kb transcripts in
endothelial cells after 2 h of histamine stimulation (Fig. 4a,
inset). Although a histamine-induced upregulation of rab18
transcript was also observed in PBMNCs, the time-dependent
pattern of rab18 mRNA upregulation was not comparable
(Fig. 4a). A signi¢cant histamine-stimulated increase of the
rab18-encoding mRNA as compared to cells which were in-
Fig. 2. Northern blot analysis of the expression pattern of human
rab18 mRNA in di¡erent cell systems.
Fig. 1. Nucleotide and amino acid sequence of the human rab18 gene. a: The nucleotide sequence of the human rab18 cDNA coding region.
b: Amino acid alignment of human rab18 protein with rab18 proteins of other species. White boxes: loops; grey boxes: L-strands; dark grey
boxes: K-helices; encircled ¢gures: consecutive numbering of motifs. Black bars: switch region I and II. PM1^3 represent the phosphate/Mg2
binding motifs and G1^3 the guanine base binding motifs. The highly conserved amino acid residues are indicated in black letters.
FEBS 23202 14-1-00
U. Scha«fer et al./FEBS Letters 466 (2000) 148^154 151
cubated for the same time period without histamine was only
observed after 2 h of stimulation (78 þ 10.6%; P9 0.001).
Eight hours of histamine stimulation led to a further increase
of rab18 expression (107.1 þ 10.5%; P9 0.001).
It has to be taken into consideration that rab18 expression
decreases in untreated PBMNCs incubated for the same time
period as histamine-stimulated cells. After 2 h of incubation
the rab18 transcript level in untreated cells decreased by
33.1% as compared to freshly isolated cells (Fig. 4b). At this
time point the decrease of rab18 mRNA level in untreated
cells is statistically signi¢cant (P9 0.01). However, a hista-
mine-dependent increase of rab18 transcript can also be ob-
served when compared to freshly isolated PBMNCs (8 h:
71 þ 28.6%). Although this observation is not statistically sig-
ni¢cant, the statistically signi¢cant enhancement of rab18 ex-
pression in comparison to the relevant control groups in en-
dothelial cells and peripheral mononuclear cells indicates
histamine as a potent inducer of rab18 transcription in these
cell systems.
4. Discussion
In the present work we have identi¢ed a histamine-regu-
lated small GTPase belonging to the rab family using di¡er-
ential display. The human rab cDNA was isolated, cloned and
sequenced. Sequence analysis of the rab cDNA revealed 100%
homology with the partial sequence of the human rab18
mRNA previously isolated from skeletal muscles [25]. The
complete human rab18 amino acid sequence showed high ami-
no acid identity (98%) to the corresponding mammalian rab18
sequence isolated from mouse [3,4]. The highest degree of
conservation in the rab18 amino acid sequence of di¡erent
species was observed in the e¡ector/switch I and switch II
region. Small GTP binding proteins are thought to be molec-
ular switches, because local conformational di¡erences be-
tween GDP- and GTP-bound forms of the protein are the
cause for the interaction of rab proteins with speci¢c e¡ector
and GTPase activating proteins. The functional speci¢city of
the rab protein is thus mainly de¢ned by the amino acid
sequence of the switch I and switch II domains. The evolu-
tionarily conserved high degree of homology in the e¡ector/
Fig. 4. Histamine-induced time-dependent regulation of rab18 expression in HUVECs and PBMNCs. HUVECs (open squares) and PBMNCs
(closed triangles) were incubated with histamine (1 mM and 10 mM, respectively) for various time periods as indicated. Gene products were an-
alysed by RT-PCR, normalised to levels of GAPDH message and quanti¢ed by HPLC. a: Graphic representation of histamine-induced changes
of rab18 cDNA levels displayed as percentage of control values. (Control values for PBMNC rab18 expression were obtained from unstimu-
lated cells incubated for the same time periods as histamine-stimulated PBMNCs); inset: Northern blot analysis of histamine-induced rab18 ex-
pression in HUVECS. b: Graphic representation of the time-dependent increase of rab18 cDNA fragment in histamine-stimulated PBMNCs
displayed as a percentage of freshly isolated PBMNCs (control). Open bar: histamine-stimulated PBMNCs; black bars: unstimulated PBMNCs
incubated for indicated time periods. The results displayed are means ( þ S.E.M.) of three separate stimulations. The RT-PCRs were performed
in duplicate.
Fig. 3. Human rab18 expression pattern in a variety of organs ex-
amined by RT-PCR of normalised tissue cDNA panels (n = 3).
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switch I and switch II region of the rab18 amino acid sequen-
ces indicates that rab18 interacts with the same or closely
related e¡ector protein(s) and regulatory proteins within dif-
ferent species.
The C-terminal region of rab proteins is thought to contain
information for the correct targeting of the proteins to their
speci¢c locations within the cell [1]. Consequently the target-
ing domain is the least conserved region of the members of the
rab subfamily. The rab18 amino acid sequence downstream of
the e¡ector/switch I and switch II region is also hypervariable
in length and sequence composition in di¡erent species. The
species-dependent hypervariability includes the cysteine-con-
taining motif, CXC, which is a prerequisite for the membrane
association of rab proteins. The rab-associated CXC motif
subject to isoprenyl (geranylgeranyl) modi¢cation is conserved
in Lymnea stagnalis and Caenorhabditis briggsae. On the other
hand, the two mammalian rab18 proteins have the C-terminal
sequence CSVL. It has been discussed that the mammalian
rab18 protein is modi¢ed by the CAAX GGL transferase [3].
These observations suggest that the distinct localisation of
rab18 proteins to speci¢c compartments might be species-de-
pendent.
Cell type-speci¢c expression of rab18 mRNA was investi-
gated by Northern blot analysis. Northern blot analysis re-
vealed two mRNA species with lengths of 2.5 and 1.0 kb.
Strong signals of both transcripts were detected in polarised
cells such as venous and aortic endothelial cells. A rather
weak expression pattern was exhibited in smooth muscle cells
and non-polarised cells such as PBMNCs, monocytes and
granulocytes. In order to investigate whether the two tran-
scripts are splicing variants of the same gene, as described
for rab proteins isolated from rat [26,27], primers directed
against the start codons and the 3P-untranslated region were
constructed. RT-PCR reactions with these primers resulted in
a single band corresponding to an unspliced rab18 product
(results not shown). A di¡erence in length of the 3P-untrans-
lated region, due to di¡erent polyadenylation signals as de-
scribed for the rab11a mRNA, cannot be excluded by these
observations [28]. However, the size of the large transcript is
in accordance with the size of the rab18 transcript isolated
from mouse [4]. The origin of the small transcript awaits
further analysis.
The tissue distribution of the rab18 mRNA was assessed by
PCR ampli¢cation using normalised tissue cDNA prepara-
tions. A ubiquitous but uneven expression of the rab18
mRNA was observed in human organs. The expression pat-
tern of the human rab18 mRNA varies slightly from the ex-
pression pattern reported in mouse [3,4]. The strongest expres-
sion of human rab18 was detected in heart, liver, kidney, lung
and pancreas. A strong mouse rab18 signal was also observed
in brain. The human rab18 mRNA signal is comparatively
weak in brain. The ubiquitous expression of the rab18 tran-
script is in accordance with the Bourne hypothesis, which
points out the large number of intracellular membrane traf-
¢cking events common to all mammalian cells [29]. Further-
more, the ubiquitous expression of rab RNA does not neces-
sarily indicate an equal level of expression in the various cell
types [1]. Detailed analysis of rab18 and rab20 protein expres-
sion in mouse revealed distinct cell type-speci¢c expression
patterns in sections of mouse kidney and intestines [4].
This aspect should also be taken into consideration in re-
gard to our further ¢ndings. We were able to show that the
regulation of rab18 expression can be modi¢ed by external
factors. The stimulation of polarised (HUVECs) and non-po-
larised cells (PBMNCs) with histamine resulted in a statisti-
cally signi¢cant time- and concentration-dependent increase of
rab18 transcript in both cell types. The histamine-induced in-
crease of rab18 message in endothelial cells lasted for a period
of 24 h. Histamine-induced long-term changes in gene expres-
sion have also been shown for the histamine receptor subtype
H2 [30] and a zinc ¢nger transcription factor (unpublished
observations). In particular the continuous downregulation
of one of the histamine receptor subtypes suggests that
long-term stimulation of endothelial cells with histamine re-
sults in a new steady-state level of the cells. Although the
di¡erential receptor-mediated modulation by growth factors
and hormones has been well established for Ras proteins, a
di¡erential regulation of mammalian rab proteins has only
been shown for developmental and cell cycle events at the
post-translational level. Histamine is one of the mediators
secreted by mast cells and basophils during early in£amma-
tory events [15,31]. The release of the endogenous amine re-
sults in in£ammatory reactions induced in a variety of cell
types [18,32,33]. The histamine-induced upregulation of
rab18 mRNA indicates for the ¢rst time a link between re-
ceptor-mediated signal transduction and regulation of rab
gene expression. It also suggests a possible role of rab proteins
in in£ammation. This is in accordance with data demonstrat-
ing a signi¢cant enhancement of the basal GTPase activity in
neutrophils of severely burned patients [34]. A role of rab
proteins in immunological reactions such as antigen presenta-
tion has also been discussed previously [35]. However, the
results obtained in this study invariably lead to a number of
questions which have to be studied in more detail in order to
assess the precise e¡ect of external factors on the regulation
and function of rab proteins and the role of rab proteins in
in£ammatory/immunological reactions. For a start, the e¡ect
of histamine on rab18 protein levels in these cells has to be
elucidated. Furthermore, in view of the results obtained by
Lu«tcke et al. [4], it might also be of great interest to study
the subcellular distribution of the rab18 protein in histamine-
stimulated and unstimulated cells. In order to determine the
physiological function of the rab18 protein it is necessary to
extend from cell culture experiments to a study of rab protein
function in humans. An in£ammatory role of rab18 for exam-
ple could be established by examining rab18 protein concen-
tration and distribution in PBMNCs of septic patients.
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